Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bis(4-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic Acid Dibenzosulfoethylate
2. Bis(p-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic Acid Dibenzosulfoethylate
3. Em 652
4. Em-652
5. Iem 652
6. Ritebronii
7. Ritebronium
8. Ritetronium
9. Ritetronium Dibenzenesulfonate
10. Ritetroniy
11. Sch 57068
12. Sch57068
1. 182167-02-8
2. Em-652
3. Sch 57068
4. Sch-57068
5. 815lj9x0d1
6. Sch57068
7. 182167-02-8 (free Base)
8. (s)-3-(4-hydroxyphenyl)-4-methyl-2-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-2h-chromen-7-ol
9. Acolbifene [inn:ban]
10. Unii-815lj9x0d1
11. Em 652
12. Acolbifene [inn]
13. Chembl68055
14. Schembl406183
15. Dtxsid501318411
16. Bdbm50471255
17. Hy-16023a
18. (2s)-3-(4-hydroxyphenyl)-4-methyl-2-[4-(2-piperidin-1-ylethoxy)phenyl]-2h-chromen-7-ol
19. Cs-0007143
20. Q15633957
21. (+)-(2s)-3-(4-hydroxyphenyl)-4-methyl-2-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-2h-1-benzopyran-7-ol
22. (2s)-3-(4-hydroxyphenyl)-4-methyl-2-(4-(2-(1-piperidinyl)ethoxy)phenyl)-2h-1-benzopyran-7-ol
23. (s)-3-(4-hydroxyphenyl)-4-methyl-2-[4-[2-(1-piperidinyl)ethoxy]-phenyl]-2h-1-benzopyran-7-ol
24. 2h-1-benzopyran-7-ol, 3-(4-hydroxyphenyl)-4-methyl-2-(4-(2-(1-piperidinyl)ethoxy)phenyl)-, (2s)-
25. 2h-1-benzopyran-7-ol, 3-(4-hydroxyphenyl)-4-methyl-2-(4-(2-(1-piperidinyl)ethoxy)phenyl)-, (s)-
26. 2s)-3-(4-hydroxyphenyl)-4-methyl-2-(4-(2-piperidin-1-yl-ethoxy)phenyl)-2h-chromen-7-ol
Molecular Weight | 457.6 g/mol |
---|---|
Molecular Formula | C29H31NO4 |
XLogP3 | 5.2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | 457.22530847 g/mol |
Monoisotopic Mass | 457.22530847 g/mol |
Topological Polar Surface Area | 62.2 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 674 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Acolbifene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acolbifene, including repackagers and relabelers. The FDA regulates Acolbifene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acolbifene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Acolbifene supplier is an individual or a company that provides Acolbifene active pharmaceutical ingredient (API) or Acolbifene finished formulations upon request. The Acolbifene suppliers may include Acolbifene API manufacturers, exporters, distributors and traders.
click here to find a list of Acolbifene suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Acolbifene DMF (Drug Master File) is a document detailing the whole manufacturing process of Acolbifene active pharmaceutical ingredient (API) in detail. Different forms of Acolbifene DMFs exist exist since differing nations have different regulations, such as Acolbifene USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Acolbifene DMF submitted to regulatory agencies in the US is known as a USDMF. Acolbifene USDMF includes data on Acolbifene's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Acolbifene USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Acolbifene suppliers with USDMF on PharmaCompass.
Acolbifene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acolbifene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Acolbifene GMP manufacturer or Acolbifene GMP API supplier for your needs.
A Acolbifene CoA (Certificate of Analysis) is a formal document that attests to Acolbifene's compliance with Acolbifene specifications and serves as a tool for batch-level quality control.
Acolbifene CoA mostly includes findings from lab analyses of a specific batch. For each Acolbifene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acolbifene may be tested according to a variety of international standards, such as European Pharmacopoeia (Acolbifene EP), Acolbifene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acolbifene USP).
LOOKING FOR A SUPPLIER?